Small molecule inhibitors of membrane-bound MCL-1 and BCL-2

被引：0
|
作者：
Patel, Luv G. [1 ]
Paranal, Ronald M. [1 ]
Ryan, Jeremy [1 ]
Sarosiek, Kristopher [1 ]
Bradner, James E. [1 ]
Letai, Anthony [1 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4610
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers
    Miyamoto, Y
    Hosotani, R
    Wada, M
    Lee, JU
    Koshiba, T
    Fujimoto, K
    Tsuji, S
    Nakajima, S
    Doi, R
    Kato, M
    Shimada, Y
    Imamura, M
    ONCOLOGY, 1999, 56 (01) : 73 - 82
  • [42] BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
    Lee, Erinna F.
    Harris, Tiffany J.
    Tran, Sharon
    Evangelista, Marco
    Arulananda, Surein
    John, Thomas
    Ramnac, Celeste
    Hobbs, Chloe
    Zhu, Haoran
    Gunasingh, Gency
    Segal, David
    Behren, Andreas
    Cebon, Jonathan
    Dobrovic, Alexander
    Mariadason, John M.
    Strasser, Andreas
    Rohrbeck, Leona
    Haass, Nikolas K.
    Herold, Marco J.
    Fairlie, W. Douglas
    CELL DEATH & DISEASE, 2019, 10
  • [43] Bcl-x in CLL tumor cells: Relationship to Mcl-1 and Bcl-2/Bax ratio
    Moshynska, O
    Netifeld, H
    Saxena, A
    FASEB JOURNAL, 2005, 19 (04): : A507 - A507
  • [44] Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers
    Krajewska, M
    Krajewski, S
    Epstein, JI
    Shabaik, A
    Sauvageot, J
    Song, K
    Kitada, S
    Reed, JC
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (05): : 1567 - 1576
  • [45] Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Indazole Derivatives as Bcl-2/Mcl-1 Dual Inhibitors
    Luo, Xi
    Deng, Xu
    Ruan, Jingyi
    Wang, Wenyan
    Wan, Yichao
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (06) : 1109 - 1114
  • [46] Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Indazole Derivatives as Bcl-2/Mcl-1 Dual Inhibitors
    Xi Luo
    Xu Deng
    Jingyi Ruan
    Wenyan Wang
    Yichao Wan
    Russian Journal of General Chemistry, 2022, 92 : 1109 - 1114
  • [47] Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A
    Abou Samra, Alma
    Robert, Aude
    Gov, Crystal
    Favre, Loetitia
    Eloy, Laure
    Jacquet, Eric
    Bignon, Jerome
    Wiels, Joelle
    Desrat, Sandy
    Roussi, Fanny
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 148 : 26 - 38
  • [48] Discovery and structure-activity relationship studies of novel Bcl-2/Mcl-1 dual inhibitors with indole scaffold
    Zhang, Zhenwei
    Hou, Linghui
    Bai, Lijun
    Pei, Jiying
    Zhao, Shan
    Liu, Dan
    Luan, Shenglin
    Huang, Min
    Zhao, Linxiang
    BIOORGANIC CHEMISTRY, 2022, 125
  • [49] MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells
    Bottardi, Stefania
    Guieze, Romain
    Bourgoin, Vincent
    Fotouhi-Ardakani, Nasser
    Douge, Aurore
    Darracq, Anais
    Lakehal, Yahia A.
    Berger, Marc G.
    Mollica, Luigina
    Bay, Jacques-Olivier
    Omichinski, James G.
    Milot, Eric
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : 68 - +
  • [50] The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients
    Andersen, MH
    Becker, JC
    Straten, PT
    LEUKEMIA, 2005, 19 (03) : 484 - 485
12345